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SHORT COMMUNICATION
A high molecular weight non-bombesin/gastrin releasing peptide growth
factor in small cell lung cancer
V. Macaulay, G.P. Joshi, M. Everard, I.E. Smith & J.L. Millar
Section ofMedicine, Institute of Cancer Research and Lung Unit, Royal Marsden Hospital, Sutton, Surrey, UK.
SCLC cell lines exhibit considerable heterogeneity as regards
morphology, biochemistry and growth kinetics (Carney et
al., 1985a). 'Classic' SCLC lines commonly grow as floating
aggregates (morphology type I or II) and possess neuro-
secretory granules (NSG) on electron microscopy. They
express four biomarkers: creatine kinase-BB (CK-BB),
neurone specific enolase (NSE), dopa decarboxylase (DDC)
and bombesin-like immunoreactivity (BLI), the latter attribu-
table to the mammalian homologue of bombesin, gastrin
releasing peptide (GRP; Brown et al., 1980). 'Variant'
cultures usually grow in suspension as single cells or loose
clusters (type III morphology), or as an adherent monolayer
(type IV). They proliferate more rapidly than the classic
lines, lack NSG and fail to express DDC and BLI (Carney et
al., 1985a). Recent work suggests a special role for
bombesin/GRP in SCLC. The cells possess specific, high
affinity bombesin receptors (Moody et al., 1983). Bombesin
(or the bombesin-homologous fragment of GRP, residues
14-27) is mitogenic for SCLC in vitro (Weber et al., 1985;
Carney et al., 1987). Finally, an antibombesin monoclonal
antibody has been shown (Cuttitta et al., 1985) to inhibit
SCLC growth in vitro and in vivo. Thus there is good
evidence that bombesin/GRP functions as an autocrine
growth factor in classic SCLC. However this is may not
explain rapid growth in variant lines, since these lack BLI.
Suspecting that SCLC may produce more than one growth
factor, we developed a novel mitogenicity assay to
investigate potential autocrine phenomena in 5 human lung
lines.
HC12 is a classic SCLC line (see Table I) which was grown
from a malignant pericardial effusion in a patient with
chemo- and radio-resistant SCLC (Duchesne et al., 1987). In
our laboratory it has been grown continuously (12 months
to date) in RPMI medium alone, without added foetal calf
serum (FCS) or HITES (hydrocortisone, insulin, transferrin,
oestradiol and sodium selenite; Simms et al., 1980). Prolifer-
ation of SCLC in such restricted conditions has only recently
been described (Cuttitta et al., 1987) and may reflect
increased production of autocrine growth factor(s). This
phenomenon merits attention since it provides a clean system
in which to investigate endogenous factor secretion and to
determine the effect of exogenously added factors.
HC12 cells in RPMI alone were passaged at confluence
every 10-14 days. The conditioned medium was centrifuged
(2,000rpm, 5min) to remove cell debris, stored at -20°C
and concentrated ')y lyophilisation and reconstitution in
aqueous solution. Hyperosmolarity was corrected by dialysis
against 0.9% saline' across Visking cellulose membrane
(Medicell International Ltd.; pore size 2.4nm, approximate
MW cut-off 10-12kDa). The final preparation (CM)
Table I Characterisation of SCLC cell lines
NCI reference datab
HC12 HX149 ICR-SCJ7 NCI-H69a Classic Variant
Cluster
morphology II I II/IV II I or II III or IV
NSG + + - + + -
BLI 5.8 20.7 0.56 1.7 3.7+0.9 <0.01
DDC 293 916 <0.1 240 149+33 <0.1
NSE 1,140 3,333 330 817 1,472+239 422+88
CK-BB 9,870 8,360 6,567 15,921 6,190+903 5,878+113
Designation Classic Classic Variant Classic
Human lung lines HC12, HX147 and HX149 were a gift of Dr G. Duchesne, Institute of
Cancer Research, Surrey. Cell line NCI-H69 was provided by Dr D.N. Carney, Mater Hospital,
Dublin. ICR-SC17 was derived in our laboratory from a lymph node biopsy in a 61-year-old
male smoker with a pulmonary mass and superior vena caval obstruction. The classic lines
HC12, HX149 and NCI-H69 were cultured in RPMI 1640 medium with penicillin (10OUml-1),
streptomycin (lOOpgml-1), glutamine (0.53mgml-1) and HITES. Variant line ICR-SC17 was
grown in HITES medium with 2% FCS. The large cell anaplastic line HX147 was maintained in
RPMI with 5-15% FCS. HC12 has also been grown continuously (>12 months) in RPMI
alone without FCS or HITES. The SCLC lines were characterised morphologically by light and
electron microscopy. Cell preparations were assayed for BLI, DDC, NSE and CK-BB. Assays
for BLI (pmolmg-') and NSE (ngmg-1) used commercially available radioimmunoassay kits
(respectively RIA U.K. Ltd., Washington, Tyne and Wear, U.K. and Pharmacia Ltd., Milton
Keynes, UK). DDC (nmolmg ' h-1) was assayed by a modification (Okuno & Fujisawa, 1983)
of the method of Beavan et al. (1978). The 2-site monoclonal antibody assay (Jackson et al.,
1984) for CK-BB (ngmg-1) was performed by Dr R. Thompson, Cambridge, U.K. aData on
NCI-H69 from Carney et al. (1985h); bCamey et al. (1985a).
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contained about 0.5mgml-1 soluble protein, but there was
no detectable bombesin/GRP by radioimmunoassay. Using
an assay which permits the simultaneous measurement of
DNA, RNA and protein synthesis, we assessed the effect of
CM on HC12 growth and compared this response to that
obtained with GRP.
Triple label uptake assays were performed on triplicate
samples in 96-well microtitre plates. Control wells received
20 pl PBS. Test wells received 20p1 CM, or GRP (1-27,
Sigma Chemical Co. Ltd., Poole, UK or fragments 1-16 or
14-27, Peninsula Laboratories Europe Ltd., St. Helens, UK)
in 20p1 PBS. Experiments used 4-8 day old cultures of
HC12 in HITES. Single cell suspensions were washed in
unsupplemented RPMI and resuspended in the same
medium; individual wells received 6 x 103 cells in 170p1. The
plates were incubated in a humidified atmosphere of 10%
C02, 5% 02 and 85% N2. After 30h, the wells were serially
labelled with a combined preparation of 14C-thymidine
(0.4,uCi per well), 3H-uridine (0.4pCi) and 75seleno-
methionine (0.08pCi; Amersham, UK) in a total volume of
10pl per well. After 70h, the cells were collected onto filter
paper discs, and the DNA, RNA and protein were precipi-
tated with ice-cold 5% trichloroacetic acid (TCA), and
counted. A calibration curve was prepared to assess and
correct for spurious beta counts generated by the gamma
emitter.
GRP was tested at a range of concentrations spanning that
which Weber et al. (1985) found most mitogenic. GRP 1-27
(0.1-100pgml-1) failed to stimulate uptake of any label
above the control level. Label uptake was reduced below the
control level by GRP 1-16 (0.5-50ygml-1). Significant
enhancement of 14C-thymidine uptake was seen only with
the bombesin-homologous fragment GRP14-27: at 5 and
50pgml-', mean label uptake at 24h was increased by
330% and 230% respectively over the control level (P<0.01
in each case). Lesser effects were seen at 0.5pgml-1 (119%
of control at 24h, NS). Stimulation of RNA and protein
synthesis was generally less marked; GRP14-27 at 5 and
50 ugmlP- caused an increase in 3H-uridine uptake
amounting to 130% of control values at 24h (P<0.05).
75Selenomethionine uptake was enhanced by both 5 and
50pgml-1 at 24h (132% and 116% of control, NS). These
results are illustrated in Figure 1, which for clarity shows
only the most mitogenic concentrations of the whole GRP
molecule or fragments. Weber et al. (1985) showed
comparable effects on DNA synthesis (250-300% increase in
3H-thymidine uptake at 20h) with GRPP14-27 at 5igml-1.
However their reported GRP concentrations may be
inaccurate, since they used RPMI with 10% FCS (rather
than RPMI alone) in all wells; FCS has recently been shown
to contain GRP (Wiedermann et al., 1986).
In wells supplemented with CM there was more striking
evidence (Figure 1) of growth enhancement. Uptakes of 14C-
thymidine, 3H-uridine and 75selenomethionine were
increased by 680% (P<0.01), 260% (P<0.01) and 230%
(P<0.01) respectively over control levels. These results were
all significantly greater (P<0.01) than the corresponding
values for GRP. Correlation of cell number with label
uptake was achieved by performing serial cell counts and
TCA precipitation on parallel pulse-labelled plates. Assess-
ment of label incorporation confirmed significant
enhancement of DNA (P<0.01), RNA (P<0.01) and
protein synthesis (P<0.05) in wells supplemented with CM
(Figure 2a-c). This was accompanied by a significant
increase (P<0.01) in viable cell numbers (Figure 2d). To
check that mitogenic effects of CM were not simply a non-
specific effect of its soluble protein content, human serum
albumin (HSA) was tested in the triple label assay against
PBS control (data not shown). HSA (100igml-1) had no
effect on HC12 RNA or protein synthesis (110% and 100%
control respectively, NS), and 14C-thymidine uptake was
actually lower in HSA-supplemented wells (45%, P<0.05).
We have attempted to define the spectrum of activity of
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Figure 1 Effect of CM or GRP on label uptake by HC12.
* control; El GRP1-27, lOgml-'; A CM; [I GRP -16,
Spgml-1; * GRP14-27, 5pgml-'. The graphs show percent
standard dpm (# counts) or cpm (y) plotted against the time in
hours for which the cells were in contact with label. Results
represent the mean+s.e.m. (including accumulated error after
correction of ,B counts) of three wells. Where no error bars are
shown, the s.e.m. is smaller than the symbol used to represent
the mean. The 24h data were assessed by analysis of variance;
mitogenic effects were compared with control values using a two-
tailed Dunnett's test, and all other comparisons used Tukey's test
(Zar, 1984).
the putative HC12-derived growth factor by targetting the
CM against the other human lung lines. These were two
classic SCLC lines, HX149 and NCI-H69, one variant, ICR-
SC17, and a large cell anaplastic line, HX147 (see Table I
for source and characterisation data). Having shown linear
uptake of label with time, subsequent experiments used only
a single time point, 24h incubation with label.
Both classic lines showed clear enhancement of DNA
synthesis in wells supplemented with HC12 CM (Figure
3a,b). 14C-thymidine uptake was increased over control
levels in HX149 by 360% (P<0.001) and in NCI-H69 by
230% (P<0.001). RNA synthesis was also significantly
enhanced (P<0.001) in both lines, as was protein synthesis
in NCI-H69 (150% over control, P<0.01) but not in HX149
(90%).
The variant SCLC line ICR-SC17 responded (Figure 3c)
by increase in uptake of all 3 isotopes: DNA, RNA and
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Figure 2 Effect of CM on HC12 label uptake and cell number. To confirm label-uptake results obtained with HC12 CM,
duplicate pairs of plates were set up as previously described. On each of three subsequent days, after 24h pulse labelling, one plate
was harvested by TCA precipitation to assess label uptake, and in the other, viable cell numbers were counted on a
haemocytometer by trypan blue exclusion. The day 4 data were analysed for significant differences by Student's t-test.
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Figure 3 Effect of CM on label uptake by human lung cell lines. Experiments used 4-8 day old cultures in HITES (classic lines
HX149 and NCI-H69), HITES plus 2% FCS (ICR-SC17) or RPMI plus 5% FCS (HX147). Single cell suspensions were washed in
RPMI and resuspended in RPMI alone (SCLC lines) or RPMI plus 5% FCS (non-SCLC). Cells (6 x 103) in 170pl were inoculated
into wells containing 20pl PBS or CM. After 46h incubation, all wells were labelled with the combined preparation of 14C-
thymidine, 3H-uridine and 75selenomethionine. After a further incubation of 24h, label incorporation was assessed by TCA
precipitation and and y counting. The data were analysed by Student's t-test.
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protein synthesis were enhanced by 140% (P<0.05), 240%
(P<0.001) and 200% (P<0.001) respectively over control
levels. Finally the CM was targetted against a non-SCLC
line, HX147 (Figure 3d). A modest (130%, P<0.01) increase
in 14C-thymidine uptake was observed, but there was no
effect on RNA or protein synthesis.
We have taken preliminary steps to isolate and
characterise the HC12-derived growth factor activity. CM
was separated by reverse-phase HPLC (column packing
Ultrapore RPSC 5pm, Beckman) using a saline/acetonitrile
mobile phase at pH2, 45°C. Three fractions (0-20%, 20-
40% and 40-60% acetonitrile) were eluted and were tested
in the triple label uptake assay. Biological activity was
contained in the 40-60% acetonitrile fraction (data not
shown), indicating that the putative growth factor is hydro-
phobic and acid-stable. Further identification is planned.
In summary, we present here the results of studies on a
classic SCLC cell line, HC12, which grows continuously in
RPMI medium alone. We have used a novel assay to test the
mitogenic potential of HC12-derived CM. A high mol. wt
preparation, depleted of BLI, has been shown to enhance
nucleotide and protein synthesis in HC12 and also, notably,
in three other SCLC lines. We conclude that the growth
factor activity described here is immunologically unrelated to
bombesin, and is probably of high mol. wt (>10kDa).
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